Phase I Trial of Intratumoral Injection of CCL21 Gene-Modified Dendritic Cells in Lung Cancer Elicits Tumor-Specific Immune Responses and CD8+ T-cell Infiltration.
about
Phase I Trial of Intratumoral Injection of CCL21 Gene-Modified Dendritic Cells in Lung Cancer Elicits Tumor-Specific Immune Responses and CD8+ T-cell Infiltration.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年学术文章
@wuu
2017年学术文章
@zh-cn
2017年学术文章
@zh-hans
2017年学术文章
@zh-my
2017年学术文章
@zh-sg
2017年學術文章
@yue
2017年學術文章
@zh
2017年學術文章
@zh-hant
name
Phase I Trial of Intratumoral ...... and CD8+ T-cell Infiltration.
@en
type
label
Phase I Trial of Intratumoral ...... and CD8+ T-cell Infiltration.
@en
prefLabel
Phase I Trial of Intratumoral ...... and CD8+ T-cell Infiltration.
@en
P2093
P2860
P1476
Phase I Trial of Intratumoral ...... and CD8+ T-cell Infiltration.
@en
P2093
David A Elashoff
Dörthe Schaue
Edward Garon
Felicita E Baratelli
Fereidoun Abtin
Fran Rosen
Francesco M Marincola
Gerald Wang
P2860
P304
P356
10.1158/1078-0432.CCR-16-2821
P407
P577
2017-05-03T00:00:00Z